Catégorie : Network News

Molecules with anti-inflammatory, restorative properties could be key to tackling neurodegenerative disease

Molecules with anti-inflammatory, restorative properties could be key to tackling neurodegenerative disease

GlycoNet researchers are studying a group of molecules that could provide insight into treating and monitoring neurodegenerative diseases.

GlycoNet investigator presents game-changing glycomics research to the Parliamentary Health Research Caucus

GlycoNet investigator presents game-changing glycomics research to the Parliamentary Health Research Caucus

Dr. Lori Burrows shared how glycomics research is being used to develop a more effective vaccine against turberculosis.

New educational resources bolster vaccine confidence, information literacy

New educational resources bolster vaccine confidence, information literacy

GlycoNet received a NSERC PromoScience grant and partnered with the Centre for Mathematics, Science and Technology Education to develop resources that educators can use to teach the science behind vaccines and engage students in critical thinking.

New treatment could reduce tissue damage in Duchenne muscular dystrophy patients by as much as 50 per cent

New treatment could reduce tissue damage in Duchenne muscular dystrophy patients by as much as 50 per cent

A carbohydrate-derived drug shows promise as a treatment to slow progression of the most common form of muscular dystrophy.

Op-ed: Glycomics is the new frontier in bioinnovation

Op-ed: Glycomics is the new frontier in bioinnovation

Read about the future of glycomics in this op ed by GlycoNet board chair Karimah Es Sabar, republished from the Hill Times. Canada has a tremendous opportunity with continued investment in glycomics to establish global leadership and economic prosperity while at the same time solving some of the world’s most pressing challenges in health and environmental sustainability.

fr_CAFrench
Scroll to Top